Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MANTRA-VT: Ablation vs Antiarrhythmics in Ischemic VT
NCT02303639Phase 4Unknown
- Sponsor
- Central Finland Hospital District
- Start
- Apr 2015
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in ventricular tachycardia (VT) (2 arms), sponsored by Central Finland Hospital District. Primary endpoint: Number of ventricular tachycardia (VT) or ventricular fibrillation (VF) episodes at 12 months. Status: unknown.
02
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT02303639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303639.